A series of newly planned reforms are designed to entice companies to start early trials in the U.S. rather than overseas.
An article from
China competition
A series of newly planned reforms are designed to entice companies to start early trials in the U.S. rather than overseas.
Published June 23, 2026
Getty Images
FDA to launch pilot program to speed up early-stage clinical trials
HHS rolls out sweeping clinical trial reforms to counter China, RFK Jr. says
HHS proposes plan to speed up clinical trials
China closing in but US leads in biotech quality and commercial reach: survey
China’s biotech boom: record 5,215 clinical drug trials reported in 2025
Operation TrialBlazer: US FDA updates guidance to speed up drug development
BIO board spoke with national security, health officials on China, CEO says
Bigger, fewer, tougher: the new era of China-US biotech partnerships
Federal health officials aim to speed up drug development and better compete with China.
‘If we’re not careful, every drug could be made in China,’ warned former head of US Food and Drug Administration in May.
HHS launches clinical trial reforms — including new pilot programs and updated FDA guidance — to accelerate US drug development…
HHS Secretary Robert F. Kennedy Jr. wants to speed up clinical trials in the United States.“A recent study found that China…
Makary pointed to three bottlenecks: hospital contracting, ethical reviews and approvals and the Investigational New Drug…
The veteran investor says that the trove of ready-made prospects is making the global biotech ecosystem “more competitive” and…
